Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Urinary Bladder, Neurogenic

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Urinary Bladder, Neurogenic in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Urinary Bladder, Neurogenic: Dysfunction of the URINARY BLADDER due to disease of the central or peripheral nervous system pathways involved in the control of URINATION. This is often associated with SPINAL CORD DISEASES, but may also be caused by BRAIN DISEASES or PERIPHERAL NERVE DISEASES.

Research Excerpts

ExcerptRelevanceReference
"We report a case of neurogenic bladder and chronic urinary retention associated with MDMA abuse."1.35Neurogenic bladder and chronic urinary retention associated with MDMA abuse. ( Barrueto, F; Beuerle, JR, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beuerle, JR1
Barrueto, F1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Urinary Bladder, Neurogenic

ArticleYear
Neurogenic bladder and chronic urinary retention associated with MDMA abuse.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2008, Volume: 4, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Anti-Infective Agents, Urinary; Bethanechol; Central Nervous S

2008